We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+9.81%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$79.2B
AUM Growth
+$3.07B
(+4%)
Cap. Flow
-$2.3B
Cap. Flow
% of AUM
-2.9%
Top 10 Holdings %
Top 10 Hldgs %
48.93%
Holding
809
New
117
Increased
205
Reduced
335
Closed
91
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$331M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$327M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$319M |
| 4 |
Allison Transmission
ALSN
|
+$195M |
| 5 |
BA.PRA
Boeing Co 6.00% Series A Preferred Stock
BA.PRA
|
+$50M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$853M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$294M |
| 3 |
NVIDIA
NVDA
|
+$266M |
| 4 |
Netflix
NFLX
|
+$190M |
| 5 |
Meta Platforms (Facebook)
META
|
+$175M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.48% |
| 2 | Consumer Discretionary | 18.83% |
| 3 | Communication Services | 18.1% |
| 4 | Healthcare | 11.79% |
| 5 | Financials | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Nucor
NUE
$62.7B
| $55K | ﹤0.01% |
468
+368
| +368% | +$52.9K |
|
602
Otis Worldwide
OTIS
$27.7B
| $55K | ﹤0.01% |
+597
| New | +$59.9K |
|
603
Alexandria Real Estate Equities
ARE
$8.3B
| $54K | ﹤0.01% |
549
| – | – |
|
604
Carrier Global
CARR
$52.4B
| $54K | ﹤0.01% |
+794
| New | +$59.9K |
|
605
NNN REIT
NNN
$8.81B
| $54K | ﹤0.01% |
1,323
| – | – |
|
606
Kroger
KR
$34.7B
| $52K | ﹤0.01% |
+854
| New | +$50.1K |
|
607
M&T Bank
MTB
$36.1B
| $52K | ﹤0.01% |
+274
| New | +$54.5K |
|
608
Sherwin-Williams
SHW
$88.1B
| $52K | ﹤0.01% |
152
-47
| -24% | -$17.5K |
|
609
State Street Financial Select Sector SPDR ETF
XLF
$58.9B
| $52K | ﹤0.01% |
+1,072
| New | +$51.8K |
|
|
INN
610
Summit Hotel Properties
INN
$669M
| $51K | ﹤0.01% |
7,464
| – | – |
|
611
Tanger
SKT
$4.41B
| $51K | ﹤0.01% |
1,491
-221
| -13% | -$7.7K |
|
612
Americold
COLD
$4.16B
| $50K | ﹤0.01% |
2,323
+376
| +19% | +$9.1K |
|
613
American Healthcare REIT
AHR
$10.8B
| $50K | ﹤0.01% |
1,775
-320
| -15% | -$8.61K |
|
614
Coherent
COHR
$65.3B
| $49K | ﹤0.01% |
+521
| New | +$52.1K |
|
615
Corning
GLW
$138B
| $49K | ﹤0.01% |
1,033
+684
| +196% | +$32.4K |
|
616
Kenvue
KVUE
$36.6B
| $48K | ﹤0.01% |
2,269
-1,226
| -35% | -$27.8K |
|
617
CareTrust REIT
CTRE
$9.57B
| $47K | ﹤0.01% |
1,733
-293
| -14% | -$8.75K |
|
618
HP
HPQ
$27.7B
| $47K | ﹤0.01% |
1,435
-384
| -21% | -$13.8K |
|
619
Outfront Media
OUT
$5.37B
| $47K | ﹤0.01% |
+2,566
| New | +$47.6K |
|
620
State Street
STT
$51B
| $47K | ﹤0.01% |
477
+311
| +187% | +$29.5K |
|
|
WSR
621
DELISTED
Whitestone REIT
WSR
| $47K | ﹤0.01% |
3,291
-101
| -3% | -$1.44K |
|
|
UMH
622
UMH Properties
UMH
$1.33B
| $46K | ﹤0.01% |
2,431
| – | – |
|
|
GTY
623
Getty Realty Corp
GTY
$2.02B
| $45K | ﹤0.01% |
+1,489
| New | +$47.2K |
|
|
AAT
624
American Assets Trust
AAT
$1.38B
| $44K | ﹤0.01% |
+1,681
| New | +$45.9K |
|
|
CBL
625
CBL Properties
CBL
$1.71B
| $44K | ﹤0.01% |
1,486
-352
| -19% | -$9.97K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q4 2024 Portfolio in Review
As of Q4 2024, Loomis, Sayles & Company held 809 positions worth $79.2B, up 4% from $76.2B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Loomis, Sayles & Company's Q4 2024 filing shows 117 new, 205 increased, 335 reduced and 91 closed positions. Its largest new stake was Boeing Co 6.00% Series A Preferred Stock: 886,790 shares worth $157M. The largest sale was Tesla, an estimated $853M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Loomis, Sayles & Company's largest Q4 2024 buy was Boeing Co 6.00% Series A Preferred Stock: 886,790 shares worth $157M.
- Loomis, Sayles & Company added most to Regeneron Pharmaceuticals in Q4 2024, an estimated $331M increase.
- Loomis, Sayles & Company's biggest Q4 2024 reduction was Tesla, cutting an estimated $853M.
- Loomis, Sayles & Company fully exited Medpace in Q4 2024, selling an estimated $68.7M.
- Loomis, Sayles & Company's ten largest holdings make up 49% of its $79.2B portfolio in Q4 2024.
- Loomis, Sayles & Company opened 117 new positions and closed 91 in Q4 2024.
- Loomis, Sayles & Company's portfolio value rose 4% quarter-over-quarter to $79.2B.
Based on Loomis, Sayles & Company's 13F filing for Q4 2024, filed 12 Feb 2025.